首页> 外文期刊>The Journal of Urology >Endoscopic treatment of urinary incontinence: long-term evaluation of the results.
【24h】

Endoscopic treatment of urinary incontinence: long-term evaluation of the results.

机译:内窥镜治疗尿失禁:长期评估结果。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: We report on the use of polydimethylsiloxane for endoscopic treatment of urinary incontinence in children with neurogenic bladder and discuss our results to determine optimal criteria for patient selection. MATERIALS AND METHODS: A total of 44 children (19 males) have been treated endoscopically for urinary incontinence since 1995. Etiology was spina bifida in 35 cases. Previous surgery had been performed on 24 patients, including bladder neck reconstruction with (17) or without bladder augmentation. Mean patient age at injection was 13 years (range 7 to 17). A single transurethral injection was given in 23 cases, 2 in 17 and 3 or more in 4. Mean volume at each injection was 3.5 cc and for each patient the total volume injected was 5.7 cc. Mean delay between 2 injections was 6 months (range 3 to 15). RESULTS: Followup ranged from 6 to 53 months (median 28). Of the patients 15 (34%) are dry (continent greater than 4 hours, no urinary pad during the day), 11 (25%) are improved (continent 2 to 3 hours, occasional pad) and 18 had poor results. In the entire series only gender and preoperative hyperactivity influenced the results, as the best results were achieved in females with a stable bladder (44% of girls versus 21% of boys were cured). Good results persisted at 12-month followup in patients treated with only 1 injection (until 36 months for older patients) and after the last of 2 injections. Of the patients treated with 3 or more injections 1 was dry at 12-month followup and treatment failed in 3. CONCLUSIONS: Injection of polydimethylsiloxane at the bladder neck achieved continence in 34% of neurogenic bladder cases. Results were better in girls with a stable bladder. Results deteriorated in the first 12 months of followup. No more than 3 injections are advised if a satisfactory result is not achieved.
机译:目的:我们报道了使用聚二甲基硅氧烷内镜治疗神经源性膀胱患儿尿失禁的情况,并讨论了我们的结果,以确定为患者选择的最佳标准。材料与方法:自1995年以来,共对44例儿童(19例男性)进行了内镜治疗尿失禁。病因是脊柱裂35例。先前已对24例患者进行了手术,包括在(17)或不进行膀胱增大的情况下进行了膀胱颈重建。注射时的平均患者年龄为13岁(范围为7至17)。 23例单次经尿道注射,17例中2例,4例中3例或更多。每次注射的平均量为3.5 cc,每位患者的总注射量为5.7 cc。两次注射之间的平均延迟为6个月(范围为3到15)。结果:随访时间为6到53个月(中位数28)。患者中有15名(34%)干燥(大陆时间超过4小时,白天没有尿垫),有11名(25%)好转(大陆2至3小时,偶尔有尿垫),而18名患者的结果较差。在整个系列中,只有性别和术前多动会影响结果,因为在膀胱稳定的女性中,最好的结果是达到最佳的(女孩治愈44%,男孩治愈21%)。在仅注射1次的患者中随访12个月(对于老年患者直到36个月)以及在2次注射的最后一次之后,仍保持良好的结果。在接受3次或更多次注射治疗的患者中,在12个月的随访中1次干燥,而在3次治疗中失败。结论:在34%的神经源性膀胱病例中,在膀胱颈处注射聚二甲基硅氧烷实现了节制。膀胱稳定的女孩的结果更好。随访的前12个月结果恶化。如果不能获得满意的结果,建议注射次数不超过3次。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号